Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 13 of the 29 sources its claims cite were checked for support.
Abstract
In many cells and specially in muscle, mitochondria form elongated filaments or a branched reticulum. We show that Mfn2 (mitofusin 2), a mitochondrial membrane protein that participates in mitochondrial fusion in mammalian cells, is induced during myogenesis and contributes to the maintenance and operation of the mitochondrial network. Repression of Mfn2 caused morphological and functional fragmentation of the mitochondrial network into independent clusters. Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak. We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression. In all, our data indicate that Mfn2 expression is crucial in mitochondrial metabolism through the maintenance of the mitochondrial network architecture, and reduced Mfn2 expression may explain some of the metabolic alterations associated with obesity.
Overview
CoChat Summary
TL;DR
Mitofusin-2 (Mfn2), a mitochondrial membrane protein induced during myogenesis, is required to maintain the elongated, intralumenally connected mitochondrial network in muscle cells and to sustain mitochondrial metabolism. Mfn2 expression is reduced in skeletal muscle of obese Zucker rats and obese humans, suggesting its loss contributes to the metabolic alterations of obesity.
Key findings
- Mfn2 mRNA (4.7 kb) is predominant in skeletal muscle and heart, and Mfn2 mRNA and protein are markedly induced during L6E9 myoblast differentiation into myotubes, in parallel with development of an extensive mitochondrial network.
- Antisense repression of Mfn2 in L6E9 myotubes (≈50% reduction in mitochondrial extracts) fragmented the network: 82% of mitochondrial filaments were longer than 5 µm in control cells versus only 22% in antisense cells. Laser microirradiation showed loss of membrane potential spread across the whole network in controls but only a very reduced extension in antisense myotubes.
- Mfn2 repression reduced mitochondrial function: glucose oxidation fell by 30% in myotubes and by 30% (or 70% per the Discussion) in 10T1/2 antisense clones; mitochondrial membrane potential fell by nearly 60%; oxygen consumption fell 30%, with coupled respiration unchanged and proton-leak-linked respiration significantly reduced.
- In obesity, Mfn2 mRNA was 34% lower in Zucker obese rats and 36% lower in obese humans; Mfn2 protein was 39% lower (rats) and 43% lower (humans). Obese rat muscle showed higher mitochondrial density (11.2 ± 0.6 vs 8.2 ± 0.5 organelles/10 µm², p < 0.001), 42% greater total mitochondrial surface area, and 25% lower volume per unit area, consistent with a smaller, fragmented network.
Methods
- Differential screening by PCR-select cDNA subtraction on gastrocnemius muscle from obese (fa/fa) versus lean (fa/+) Zucker rats isolated the 321-bp C31 clone, identified as Mfn2; expression was confirmed by Northern blot, competitive-quantitative RT-PCR, and Western blot with an anti-Mfn2 peptide antibody.
- Human samples: vastus lateralis biopsies from 13 healthy lean volunteers (51 ± 2 years; BMI 23 ± 1 kg/m²; insulin 34 ± 2 pmol/liter) and 9 obese volunteers (46 ± 2 years; BMI 34 ± 1 kg/m²; insulin 62 ± 6 pmol/liter), taken before a 3-h euglycemic hyperinsulinemic clamp (insulin 12 pmol/kg/min); obese subjects showed 50% lower insulin-stimulated glucose disposal (4.9 ± 0.8 vs 10.1 ± 1.1 mg/kg/min).
- Functional work used transient Mfn2 overexpression and antisense knockdown (stable transfection in 10T1/2 fibroblasts; adenoviral antisense in L6E9 myotubes), with confocal immunofluorescence/MitoTracker/JC-1 imaging, laser microirradiation, electron microscopy, [¹⁴C]glucose oxidation, and Clark-electrode respiration measurements; mitochondrial volume/surface area in soleus muscle was quantified by the vertical sections stereological method (4 obese and 4 lean rats, 80 photographs/group at 5,000×).
Limitations
- The paper states that further studies in rodents after recombinant ablation of Mfn2 are required to determine whether it contributes to obesity, and it notes that the mechanism by which Mfn2 supports respiratory chain activity is only postulated (destabilization/reduced activity of certain complexes), not demonstrated.
- The authors note that not all L6E9 myoblasts differentiate in culture (≈30% remain undifferentiated) and that undifferentiated myoblasts are not infected by adenovirus, so the observed reduction in glucose oxidation after antisense infection is a substantial underestimate of the actual inhibition.
- Evident from the text: the human data are cross-sectional and correlational (n = 13 lean, 9 obese), so causality between reduced Mfn2 and obesity-related metabolic alterations is not established; the mitochondrial network/morphology measurements in obesity were made only in Zucker rats, not in human muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 8 Not checked · 69 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression.”
- Also stated in: § Abstract · plain
“We also show that this regulatory mechanism is disturbed in obesity.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In myoblast cells, a short portion of a mitochondrial filament became de-energized when one of the cluster-composing mitochondria was damaged by laser (Fig. 3,C and D). As a consequence of the loss of mitochondrial membrane potential, mitochondria became unstained by JC-1.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under these conditions, we found that myogenesis caused the induction of Mfn2 protein in L6E9 cells (Fig. 2C).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 84 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid overloading promotes fast and transient changes in mitochondrial architecture.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the above observations, obese patients display a largely fragmented mitochondrial network in skeletal muscle (Bach et al, 2003).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mfn2 is a nuclear-encoded mitochondrial protein that shows homology with Drosophila or yeast Fzo proteins (26,27) and is highly expressed in skeletal muscle, the heart, and the brain (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and mitochondria from obese Zucker rats show higher mitochondrial surface, lower mitochondrial volume, and a lower extent of the mitochondrial network (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ RESULTS
“Repression of Mfn2 in 10T1/2 cells also reduced glucose oxidation by 307 (Fig. 8C).”
§ DISCUSSION
“cellular repression of Mfn2 in 10T1/2 cells (687 reduction) reduces mitochondrial proton leak and cellular oxygen consumption (307 reduction) and glucose oxidation (707 reduction)”
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Alexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Estimation of surface area from vertical sections
Baddeley, A. J., Gundersen, H. J. G., & Cruz‐Orive, L. M. (1986) · Journal of Microscopy · doi:10.1111/j.1365-2818.1986.tb04282.x · Cited by 1,058
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Control of mitochondrial morphology by a human mitofusin
Santel, A., & Fuller, M. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.867 · Cited by 1,012
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Smirnova, E., Shurland, D.-L., Ryazantsev, S. N., & van der Bliek, A. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.351 · Cited by 733
Research works printed but not linked: 3
- Astrup, 1987, Int. J. Obesity, 11, 51
- Kaplan, 1991, Int. J. Obesity, 15, 809
- Buchberger, 1996, Am. J. Physiol., 271, R472
Cited by
Items 101–200 of 829
Diet impact on mitochondrial bioenergetics and dynamics
Putti, R., Sica, R., Migliaccio, V., & Lionetti, L. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00109 · Cited by 192
“A decreased mitochondrial proton leak and increased bioenergetics efficiency in Mfn2-depleted cells has been demonstrated (Bach et al., 2003).”
BackgroundRangwala, S. M., Wang, X., Calvo, J. A., Lindsley, L., Zhang, Y., Deyneko, G., Beaulieu, V., Gao, J., Turner, G., & Markovits, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125401 · Cited by 190
Tur, J., Pereira-Lopes, S., Vico, T., Marín, E. A., Muñoz, J. P., Hernández-Alvarez, M., Cardona, P.-J., Zorzano, A., Lloberas, J., & Celada, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108079 · Cited by 191
“Mfn2 is a ubiquitous protein, with particularly high expression in brain, heart, and skeletal muscle (Bach et al., 2003).”
BackgroundSelf-citationKonopka, A. R., Suer, M. K., Wolff, C. A., & Harber, M. P. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glt107 · Cited by 187
Mitochondrial Dynamics in Mitochondrial Diseases
Suárez-Rivero, J., Villanueva-Paz, M., De la Cruz-Ojeda, P., De la Mata, M., Cotán, D., Oropesa-Ávila, M., De Lavera, I., Álvarez-Córdoba, M., Luzón-Hidalgo, R., & Sánchez-Alcázar, J. (2016) · Diseases · doi:10.3390/diseases5010001 · Cited by 187
“Mitochondrial size is reduced in the skeletal muscle of obese and type 2 diabetic patients compared to lean subjects [101].”
BackgroundMitochondrial Dynamics in Basal and Stressful Conditions
Zemirli, N., Morel, E., & Molino, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020564 · Cited by 184
“This is expected considering that both Drp1 and Mfn2 are essential for proper brain development [80,88,89].”
BackgroundInfluentialMitofusin 2 Protects Cerebellar Granule Neurons against Injury-induced Cell Death
Jahani-Asl, A., Cheung, E. C. C., Neuspiel, M., MacLaurin, J. G., Fortin, A., Park, D. S., McBride, H. M., & Slack, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703812200 · Cited by 185
Mitochondrial function in development and disease
Rossmann, M. P., Dubois, S. M., Agarwal, S., & Zon, L. I. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048912 · Cited by 184
Morphological dynamics of mitochondria — A special emphasis on cardiac muscle cells
Hom, J., & Sheu, S.-S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.023 · Cited by 181
“The expression ofMfn1 andMfn2 in rat and mouse heart has also been detected by RT-PCR [109,110].”
MethodThe role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180
“…and Fuller 2001), is defective in a hereditary form of progressive axonal sensory polyneuropathy, known as Charcot-Marie-Tooth type 2A (Zuchner et al. 2004). mitofusin 2 defects result in a hyper-fragmented mitochondrial network and mitochondrial dysfunction (Bach et al. 2003; Honda et al. 2005).”
BackgroundPedrola, L., Espert, A., Wu, X., Claramunt, R., Shy, M. E., & Palau, F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi121 · Cited by 179
“Interestingly, the cytoplasmic medium-sized vesicles we observed when overexpressing GDAP1 by transient transfection in COS-7 cells were really spheroidal mitochondria that may represent the collapse of the mitochondrial network (29).”
BackgroundMitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1β
Liesa, M., Borda-d'Água, B., Medina-Gómez, G., Lelliott, C. J., Paz, J. C., Rojo, M., Palacín, M., Vidal-Puig, A., & Zorzano, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003613 · Cited by 174
“In addition, we have previously reported that Mfn2 can modulate mitochondrial activity through changes in the electron transport chain (ETC) and this modulation is independent of its role in mitochondrial morphology [1,6].”
BackgroundResultInfluentialSelf-citationH2O2-induced mitochondrial fragmentation in C2C12 myocytes
Fan, X., Hussien, R., & Brooks, G. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.024 · Cited by 173
“It has been shown that obese and type II diabetic human subjects [45] and obese rats [29] display smaller skeletal muscle mitochondria than their lean counterparts.”
BackgroundMetabolic implications of organelle–mitochondria communication
Gordaliza‐Alaguero, I., Cantó, C., & Zorzano, A. (2019) · EMBO reports · doi:10.15252/embr.201947928 · Cited by 172
“Thus, Mfn2 is repressed in the muscles of obese Zucker rats [143].”
Self-citationThe cell-type specificity of mitochondrial dynamics
Kuznetsov, A. V., Hermann, M., Saks, V., Hengster, P., & Margreiter, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.007 · Cited by 169
Exercise-induced hormesis and skeletal muscle health
Ji, L. L., Kang, C., & Zhang, Y. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.025 · Cited by 172
Regulation of Mitochondrial Structure and Dynamics by the Cytoskeleton and Mechanical Factors
Bartolák-Suki, E., Imsirovic, J., Nishibori, Y., Krishnan, R., & Suki, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081812 · Cited by 169
“However, if fission is not controlled and balanced by fusion, the network becomes too fragmented which leads to glucose oxidation, mitochondrial inner membrane potential decline, and hence the downregulation of ATP production [8].”
BackgroundIqbal, S., Ostojic, O., Singh, K., Joseph, A., & Hood, D. A. (2013) · Muscle & Nerve · doi:10.1002/mus.23838 · Cited by 169
“Mitochondrial morphology is altered during muscle development(1) and in various disease conditions, including diabetes(2,3) and obesity.(3,4) These changes in morphology are mediated by a balance of organelle fusion and fission events.”
BackgroundMitochondrial quality control in human health and disease
Liu, B.-H., Xu, C.-Z., Liu, Y., Lu, Z.-L., Fu, T.-L., Li, G.-R., Deng, Y., Luo, G.-Q., Ding, S., Li, N., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00536-5 · Cited by 171
Mitochondrial dynamics in the central regulation of metabolism
Nasrallah, C. M., & Horvath, T. L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.160 · Cited by 166
Methods for Assessing Mitochondrial Function in Diabetes
Perry, C. G. R., Kane, D. A., Lanza, I. R., & Neufer, P. D. (2013) · Diabetes · doi:10.2337/db12-1219 · Cited by 166
Drp1-Mediated Mitochondrial Abnormalities Link to Synaptic Injury in Diabetes Model
Huang, S., Wang, Y., Gan, X., Fang, D., Zhong, C., Wu, L., Hu, G., Sosunov, A. A., McKhann, G. M., Yu, H., et al. (2015) · Diabetes · doi:10.2337/db14-0758 · Cited by 165
“Imbalances of mitochondrial fission and fusion in diabetes result predominantly from upregulation of Drp1, which induces mitochondrial division and dysfunction (impaired respiration and ATP production) in a variety of cell types, including islet cells (26), hepatocytes (27), skeletal muscle cells (9,28), mononuclear b…”
Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration
Morán, M., Moreno-Lastres, D., Marín-Buera, L., Arenas, J., Martín, M. A., & Ugalde, C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.009 · Cited by 163
“In agreement, lower H2O2 doses induced mitochondrial hyperfusion associated with decreased Fis1 expression levels and augmented Mfn1 and Mfn2 [245].”
BackgroundInfluentialXian, H., & Liou, Y.-C. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00657-z · Cited by 164
Pearen, M. A., Myers, S. A., Raichur, S., Ryall, J. G., Lynch, G. S., & Muscat, G. E. O. (2008) · Endocrinology · doi:10.1210/en.2007-1202 · Cited by 158
Mitochondrial coupling defect in Charcot–Marie–Tooth type 2A disease
Loiseau, D., Chevrollier, A., Verny, C., Guillet, V., Gueguen, N., Pou De Crescenzo, M., Ferré, M., Malinge, M., Guichet, A., Nicolas, G., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21086 · Cited by 156
“Second, changes in the expression level of MFN2 have recently been reported to be involved in the modulation of cellular energy balance.(19,36,37) The expression of MFN2 is upregulated after exercise and weight loss, and downregulated in obese and diabetic patients.”
BackgroundPennanen, C., Parra, V., López-Crisosto, C., Morales, P. E., del Campo, A., Gutierrez, T., Rivera-Mejías, P., Kuzmicic, J., Chiong, M., Zorzano, A., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.139394 · Cited by 157
“Cardiomyocytes transduced with an antisense adenovirus targeting the fusion protein Mfn2 (AsMfn2) (Bach et al., 2003) displayed a fragmented mitochondrial network (supplementary material Fig.”
BackgroundSelf-citationMitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases
Theurey, P., & Rieusset, J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.002 · Cited by 176
Lokireddy, S., Wijesoma, I. W., Teng, S., Bonala, S., Gluckman, P. D., McFarlane, C., Sharma, M., & Kambadur, R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.005 · Cited by 154
RetractedRole of mitofusin 2 mutations in the physiopathology of Charcot–Marie–Tooth disease type 2A
Cartoni, R., & Martinou, J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.003 · Cited by 171
“The implication of Mfn2 in cell bioenergetics was first proposed by Zorzano et al. They reported that a down-regulation of Mfn2 in L6E9 myotubes induced a reduction in glucose oxidation andmitochondrial membrane potential (Bach et al., 2003).”
BackgroundMitofusin 2: A Mitochondria-Shaping Protein with Signaling Roles Beyond Fusion
de Brito, O. M., & Scorrano, L. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1934 · Cited by 152
“In vivo and in vitro models show that physiologic and patho-physiologic conditions characterized by altered glucose oxidation, such as diabetes, obesity, insulin resistance, exercise, and weight loss, lead to changes in MFN2 expression (4, 71).”
(De)constructing Mitochondria: What For?
Dimmer, K. S., & Scorrano, L. (2006) · Physiology · doi:10.1152/physiol.00010.2006 · Cited by 152
“The picture is probably oversimplified, since Mfn2 appears to be a pleiotropic protein regulating many other cellular functions, from oxidative metabolism (7, 8) to cell proliferation (21).”
Backgroundde Brito, O. M., & Scorrano, L. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.02.005 · Cited by 152
“The differences between the two mitofusins extend to a broader involvement of MFN2 in several pathophysiological conditions that include diabetes (Bach et al., 2003), vascular proliferative disorders (Chen et al., 2004) and Charcot-Marie-Tooth type 2A neuropathy (CMT2A) (Zuchner et al., 2004).”
BackgroundInsulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 173
Chaudhari, S. N., & Kipreos, E. T. (2017) · Nature Communications · doi:10.1038/s41467-017-00274-4 · Cited by 151
Xie, W., & Chung, K. K. K. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07769.x · Cited by 150
“(2012) 10.1111/j.1471-4159.2012.07769.x (Legros et al. 2002; Bach et al. 2003; Chen et al. 2003, 2007; Berman et al. 2008).”
InfluentialDing, H., Jiang, N., Liu, H., Liu, X., Liu, D., Zhao, F., Wen, L., Liu, S., Ji, L. L., & Zhang, Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.007 · Cited by 162
Mitochondrial fusion is essential for steroid biosynthesis
Duarte, A., Poderoso, C., Cooke, M., Soria, G., Cornejo Maciel, F., Gottifredi, V., & Podestá, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045829 · Cited by 149
“Even when several lines of evidence support a regulation of Mnf2 by diverse metabolic conditions as type 2 diabetes and obesity [23], modulation in Mnf2 levels has not been demonstrated under hormonal regulation of different cellular functions.”
BackgroundAraya, L. E., Soni, I. V., Hardy, J. A., & Julien, O. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00456 · Cited by 156
Mitochondrial fission and fusion dynamics: the long and short of it
Berman, S., Pineda, F. J., & Hardwick, J. M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.57 · Cited by 163
“Subsequently, the mammalian counterparts, Mfn1 and Mfn2, were reported to mediate mitochondrial fusion, though this conclusion was also based on short mitochondrial morphology when the function of Mfn1/Mfn2 was impaired.(29,30) While these studies in yeast are compelling, it remains possible that the effects of mutati…”
BackgroundMitochondrial response to nutrient availability and its role in metabolic disease
Gao, A. W., Cantó, C., & Houtkooper, R. H. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303782 · Cited by 148
“Studies in Zucker rats and obese humans have shown that Mfn2 was strongly decreased in their skeletal muscle tissues compared to the control groups, which was associated with smaller mitochondrial network and size (Bach et al , 2003).”
Molecular regulation of mitochondrial dynamics in cardiac disease
Nan, J., Zhu, W. M., Rahman, M. S. U., Liu, M., Li, D. X., Su, S., Zhang, N., Hu, X., Yu, H., Gupta, M. P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.03.006 · Cited by 160
Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation
Touvier, T., De Palma, C., Rigamonti, E., Scagliola, A., Incerti, E., Mazelin, L., Thomas, J.-L., D'Antonio, M., Politi, L., Schaeffer, L., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.595 · Cited by 140
“This kind of rearrangement has been observed in cellular models defective in fission or fusion proteins expression.(5,34,35) Little, however, is known on the”
BackgroundImpaired Mitochondrial Dynamics and Bioenergetics in Diabetic Skeletal Muscle
Liu, R., Jin, P., LiqunYu, Wang, Y., Han, L., Shi, T., & Li, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092810 · Cited by 146
“A series findings by Zorzano’s group also showed that altered expression of OPA1 and decreased expression of MFN2 participated in the development of obesity and type 2 diabetes in both patients and rodent models [32,34,35,36,37], which highlighted the importance of MFN2 in metabolism.”
BackgroundDebard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio, B., Boirie, Y., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1394-7 · Cited by 161
“We also found no difference in mRNA expression of pyruvate dehydrogenase kinase 4 (PDK4) and mitofusin-2 (Mfn-2), a recently characterised protein that may participate in maintenance of the mitochondrial network [27].”
BackgroundSelf-citationA cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis
Pellegrini, L., & Scorrano, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402145 · Cited by 158
“Mfn2 seems to have an additional role in determining the efficiency of mitochondrial oxidative metabolism.(29) It is conceivable that relative expression levels of these players dictate mitochondrial morphology in different cell types and during development.”
Lionetti, L., Mollica, M. P., Donizzetti, I., Gifuni, G., Sica, R., Pignalosa, A., Cavaliere, G., Gaita, M., De Filippo, C., Zorzano, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092753 · Cited by 144
“Moreover, a reduction in mitochondrial fusion may be involved in the development of obesity and IR [12].”
BackgroundResultSelf-citationGebara, E., Zanoletti, O., Ghosal, S., Grosse, J., Schneider, B. L., Knott, G. W., Astori, S., & Sandi, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.003 · Cited by 163
“Given that MFN2 is a mitochondrial fusion molecule (82), it may seem counterintuitive that, with lower MFN2 levels, mitochondria in the NAc of HA rats are not smaller and more numerous than in LA rats.”
Fealy, C. E., Mulya, A., Lai, N., & Kirwan, J. P. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01064.2013 · Cited by 140
“Muscle mitochondria from patients with type 2 diabetes, observed by electron microscopy, are smaller in size compared with nondiabetic controls (22), a morphological characteristic that is partially rescued by exercise training (58), while protein expression studies indicate a profragmentary environment in muscle from…”
BackgroundNitric oxide and mitochondrial biogenesis: A key to long-term regulation of cellular metabolism
Clementi, E., & Nisoli, E. (2005) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpb.2005.04.022 · Cited by 158
The many shapes of mitochondrial death
Cereghetti, G. M., & Scorrano, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209605 · Cited by 166
“Moreover, levels of Mfn2 regulate oxidative metabolism in muscle mitochondria and are diminished in obese patients as well as in a rat model of type II diabetes (Bach et al., 2003); levels of Mfn2 can also control neointimal proliferation in models of hypertension (Chen et al., 2004).”
BackgroundChang, D. T. W., & Reynolds, I. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.034 · Cited by 141
Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
“…to mitochondrial function include nuclear respiratory factor (NRF) (66), the estrogen-related receptor (ERR) nuclear receptor family (67,68), mitofusin 2 (69,70), PSARL (71), eNOS (72), assembly factors (e.g., OPA and surfeit) (73), calcineurin (74), and calcium = calmodulin-dependent protein (75).”
Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins
Yu, C.-Y., Liang, J., Li, J., Lee, Y.-L., Chang, B.-L., Su, C.-I., Huang, W.-J., Lai, M. M. C., & Lin, Y. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005350 · Cited by 148
“metabolism [53,54], cell death involvement [55,56] and ER location in addition to mitochondria [19].”
BackgroundHuman Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
Basit, F., Mathan, T. S. M., Sancho, D., & de Vries, I. J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02489 · Cited by 149
The Role of Impaired Mitochondrial Lipid Oxidation in Obesity
Rogge, M. M. (2009) · Biological Research For Nursing · doi:10.1177/1099800408329408 · Cited by 134
“Low Basal ATP Production Obese people have much smaller mitochondria with lower energy-generating capacity than nonoverweight people (Bach et al., 2002; Kelley, He, Menshikova, & Ritov, 2002; Ritov et al., 2005).”
BackgroundDown-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo
Lu, F. Y., Moore, X., Gao, X., Dart, A. M., Lim, Y. L., & Du, X. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.003 · Cited by 135
Crosstalk between mitochondrial (dys)function and mitochondrial abundance
Michel, S., Wanet, A., De Pauw, A., Rommelaere, G., Arnould, T., & Renard, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23021 · Cited by 133
“MNF2 also controls mitochondrial metabolism, asMfn2 loss-of-function reduces glucose oxidation, decreasesDcm, and lowers oxygen consumption and mitochondrial proton leak in cultured cells (Bach et al., 2003; Chen et al., 2005; Pich et al., 2005).”
BackgroundInfluentialSarcolipin: A Key Thermogenic and Metabolic Regulator in Skeletal Muscle
Pant, M., Bal, N. C., & Periasamy, M. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.08.006 · Cited by 132
“Mfn2 Mfn2 repression in myotubes Decreased glucose oxidation, decreased respiration [93]”
Moore, T. M., Zhou, Z., Cohn, W., Norheim, F., Lin, A. J., Kalajian, N., Strumwasser, A. R., Cory, K., Whitney, K., Ho, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.11.012 · Cited by 131
The changing shape of mitochondrial apoptosis
Wasilewski, M., & Scorrano, L. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.03.007 · Cited by 131
Miret‐Casals, L., Sebastián, D., Brea, J. M., Rico-Leo, E. M., Palacín, M., Fernández‐Salguero, P. M., Loza, M. I., Alberício, F., & Zorzano, A. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.12.001 · Cited by 136
Self-citationMechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy
Leinninger, G. M., Edwards, J. L., Lipshaw, M. J., & Feldman, E. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0320 · Cited by 147
Boscolo, A., Milanović, D., Starr, J. A., Sanchez, V., Oklopcic, A., Moy, L., Ori, C., Erişir, A., & Jevtović‐Todorović, V. (2013) · Anesthesiology · doi:10.1097/aln.0b013e318289bc9b · Cited by 133
Boguszewska, K., Szewczuk, M., Kaźmierczak-Barańska, J., & Karwowski, B. T. (2020) · Molecules · doi:10.3390/molecules25122857 · Cited by 127
“, metabolic disorder, neurodegeneration) [68,69].”
Regulation of mitochondrial fission by intracellular Ca2+ in rat ventricular myocytes
Hom, J., Yu, T., Yoon, Y., Porter, G., & Sheu, S.-S. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.03.018 · Cited by 127
Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance
Zorzano, A., Liesa, M., & Palacín, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802676335 · Cited by 124
“In keeping with the observations in obese Zucker rats, skeletal muscle of obese subjects also shows a reduced expression of Mfn2 mRNA compared to lean subjects (Bach et al., 2003, 2005).”
BackgroundInfluentialSelf-citationHuang, P., Galloway, C. A., & Yoon, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020655 · Cited by 124
“In addition, genetic dysregulation of the mitochondrial fusion protein Mfn2 has been associated with vascular proliferative disorders [23], as well as obesity and type 2 diabetes [24].”
BackgroundFunctional coordination of alternative splicing in the mammalian central nervous system
Fagnani, M., Barash, Y., Ip, J. Y., Misquitta, C., Pan, Q., Saltzman, A. L., Shai, O., Lee, L., Rozenhek, A., Mohammad, N., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-6-r108 · Cited by 120
Dahl, R., Larsen, S., Dohlmann, T. L., Qvortrup, K., Helge, J. W., Dela, F., & Prats, C. (2015) · Acta Physiologica · doi:10.1111/apha.12289 · Cited by 111
De Palma, C., Falcone, S., Pisoni, S., Cipolat, S., Panzeri, C., Pambianco, S., Pisconti, A., Allevi, R., Bassi, M. T., Cossu, G., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.48 · Cited by 120
Axelrod, C. L., Fealy, C. E., Mulya, A., & Kirwan, J. P. (2019) · Acta Physiologica · doi:10.1111/apha.13216 · Cited by 121
“Furthermore, impairments in mitochondrial fusion have been observed in obese rats and humans.(34) In contrast, cells exposed to nutrient deprivation develop elongated tubules, and are protected against mitophagy.”
BackgroundMulti-site control and regulation of mitochondrial energy production
Bénard, G., Bellancé, N., José, C., Melser, S., Nouette‐Gaulain, K., & Rossignol, R. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.030 · Cited by 135
Kobashigawa, S., Suzuki, K., & Yamashita, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.006 · Cited by 124
Leinninger, G. M., Backus, C., Sastry, A. M., Yi, Y.-B., Wang, C.-W., & Feldman, E. L. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.017 · Cited by 118
“Fusion proteins are also decreased in the skeletal muscle of type 2 diabetics and in obese Zucker rats (an experimental model of type 2 diabetes), which exhibit mitochondrial density changes suggestive of increased fission events (Bach et al., 2003, 2005).”
BackgroundResultJoseph, A.-M., Joanisse, D. R., Baillot, R. G., & Hood, D. A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/642038 · Cited by 117
“suggest defects in the inner membrane [83, 98, 99].”
BackgroundInfluentialExercise effects on physiological function during aging
Radak, Z., Torma, F., Berkes, I., Goto, S., Mimura, T., Posa, A., Balogh, L., Boldogh, I., Suzuki, K., Higuchi, M., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.444 · Cited by 116
Circadian Rhythms and Mitochondria: Connecting the Dots
Sardon Puig, L., Valera-Alberni, M., Cantó, C., & Pillon, N. J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00452 · Cited by 113
“In chronic situations of nutrient overload mitochondrial look rounder and smaller and this has been related to the transcriptional repression of the MFN2 gene (Bach et al., 2003).”
BackgroundInfluentialMitochondrial Dysfunction and Apoptosis in Cumulus Cells of Type I Diabetic Mice
Wang, Q., Frolova, A. I., Purcell, S. H., Adastra, K. L., Schoeller, E. L., Chi, M. M.-Y., Schedl, T., & Moley, K. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015901 · Cited by 124
“Aggregation of mitochondria has been observed in cell lines expressing MFN mutants [32,33] and MFN2-deficient neurons and myotubes [34,35].”
BackgroundOPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle
Noone, J., O’Gorman, D. J., & Kenny, H. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.003 · Cited by 131
Park, K.-S., Wiederkehr, A., Kirkpatrick, C., Mattenberger, Y., Martinou, J.-C., Marchetti, P., Demaurex, N., & Wollheim, C. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806251200 · Cited by 114
Larrea, D., Pera, M., Gonnelli, A., Quintana–Cabrera, R., Akman, H. O., Guardia‐Laguarta, C., VELASCO, K. R., Área-Gómez, E., Bello, F. D., Stefani, D. D., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz008 · Cited by 122
“The mitochondrial abnormalities found by us, and by others (9,51,57), cannot be explained simply as a result of alterations similar to those seen in authentic mitochondrial disorders due to respiratory chain deficiency (64).”
BackgroundLinking the Metabolic State and Mitochondrial DNA in Chronic Disease, Health, and Aging
Picard, M., & Turnbull, D. M. (2013) · Diabetes · doi:10.2337/db12-1203 · Cited by 113
“Expression and protein abundance of the mitochondrial fission proteins 1 (Fis1) and dynamin-related protein 1 (Drp1) increase with hyperglycemia (55,63), whereas hyperglycemia reduces both the expression and abundance of the fusion proteins mitofusin 2 (Mfn2) and optic atrophy 1 (OPA1) in cells and tissues (61,63,64).”
BackgroundRole of mitofusin 2 (Mfn2) in controlling cellular proliferation
Chen, K., Dasgupta, A., Ding, J., Indig, F. E., Ghosh, P., & Longo, D. L. (2014) · The FASEB Journal · doi:10.1096/fj.13-230037 · Cited by 112
“Apart from its major involvement in mitochondrial fusion, dysfunction of this gene is also associated with a variety of pathological conditions, including Charcot-Marie-Tooth (CMT) disease type 2A (3, 4), diabetes mellitus type 2 (5, 6), obesity (7), atherosclerosis, and hypertension (8, 9), suggesting the diverse fun…”
BackgroundMitochondrial dysfunction in schizophrenia: With a focus on postmortem studies
Roberts, R. C. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.009 · Cited by 126
“, 2004) that is also necessary for the maintenance and operation of the mitochondrial network (Bach et al., 2003) and transporting mitochondria to their proper location in axons and dendrites (Misko et al.”
BackgroundSingh, S. P., Schragenheim, J., Cao, J. J., Falck, J. R., Abraham, N. G., & Bellner, L. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.07.004 · Cited by 114
“That the dynamics of the mitochondrial fusion/fission processes need to be tightly regulated is exemplified by the link between the reduction of mitochondrial fusion and the development of obesity and insulin resistance (41;44;45).”
BackgroundMuscle function decline and mitochondria changes in middle age precede sarcopenia in mice
del Campo, A., Contreras-Hernández, I., Castro-Sepúlveda, M., Campos, C. A., Figueroa, R., Tevy, M. F., Eisner, V., Casas, M., & Jaimovich, E. (2018) · Aging · doi:10.18632/aging.101358 · Cited by 110
“Nowadays, there is significant evidence supporting a close relationship between mitochondrial function and morphology in skeletal muscle [17] [18].”
BackgroundMechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 122
“Skeletal muscle of Zucker obese rats showed decreased mitochondrial size, mitochondrial volume/unit of mitochondrial surface ratio, and MFN-2 expression (272).”
Joseph, A.-M., Pilegaard, H., Litvintsev, A., Leick, L., & Hood, D. A. (2006) · Essays in Biochemistry · doi:10.1042/bse0420013 · Cited by 111
“The impairment of lipid and carbohydrate metabolism evident in obese Zucker rats may be related to the fact that Mfn2 is signifi cantly reduced in the muscle of this animal model [27].”
BackgroundMitochondrial Fusion Proteins and Human Diseases
Ranieri, M., Brajkovic, S., Riboldi, G., Ronchi, D., Rizzo, F., Bresolin, N., Corti, S., & Comi, G. P. (2013) · Neurology Research International · doi:10.1155/2013/293893 · Cited by 110
Keeping mitochondria in shape: a matter of life and death
Scorrano, L. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12135 · Cited by 132
Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death
Riera, A. M., Segarra‐Mondejar, M., Muñoz, J. P., Ginet, V., Olloquequi, J., Pérez‐Clausell, J., Palacín, M., Reina, M., Puyal, J., Zorzano, A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488327 · Cited by 124
“The relation between autophagy and cell death is controversial (Baehrecke, 2005; Galluzzi et al, 2012).”
BackgroundSelf-citationSphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes
Roszczyc-Owsiejczuk, K., & Zabielski, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635175 · Cited by 123
Molero, J. C., Jensen, T. E., Withers, P. C., Couzens, M., Herzog, H., Thien, C. B. F., Langdon, W. Y., Walder, K., Murphy, M. A., Bowtell, D. D. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21480 · Cited by 107
“However, a role for c-Cbl in the regulation of mitochondrial fusion also seems plausible, because we did not observe a significant change in mitochondrial area in the subsarcolemmal region in muscle from c-Cbl–/– mice, and perturbations in mitochondrial fusion have been associated with modifications in both glucose an…”
BackgroundLugus, J. J., Ngoh, G. A., Bachschmid, M. M., & Walsh, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.023 · Cited by 108
“Lastly, Mfn2, but not Mfn1, has been linked to cellular functions including oxidative metabolism [44] and is induced by caloric restriction [45] and repressed in obese and diabetic individuals [46, 47].”
Spinazzi, M., Cazzola, S., Bortolozzi, M., Baracca, A., Loro, E., Casarin, A., Solaini, G., Sgarbi, G., Casalena, G., Cenacchi, G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn225 · Cited by 107
“Moreover, abnormal mitochondrial distribution had also been observed in cell models of various neurodegenerative conditions, such as MFN2 mutant neurons (34), and myotubes (35), as well as in peripheral nerves of Charcot-Marie Tooth 2A (CMT2A) patients (36), and in optic nerves of patients affected by LHON (37).”
Inhibition of mitochondrial fission favours mutant over wild-type mitochondrial DNA
Malena, A., Loro, E., Di Re, M., Holt, I. J., & Vergani, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp281 · Cited by 107
Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes
Makino, A., Suarez, J., Gawlowski, T., Han, W., Wang, H., Scott, B. T., & Dillmann, W. H. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00437.2010 · Cited by 105
“In addition, MFN2 was identified as a suppressor of obesity (2, 3) and hypertension (8).”
BackgroundMitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity
López-Lluch, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.005 · Cited by 103
“Mfn2 depleted rat muscle cells show a reduced proton leak and lower bioenergetics efficiency 22 indicated by lower glucose oxidation and mitochondrial respiration (Bach et al., 2003).”
BackgroundInfluentialDu, F., Yan, S., Yu, Q., Chen, D., & Yan, S. S. (2016) · Scientific Reports · doi:10.1038/srep31462 · Cited by 118
Metadata
- Authors
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A.
- Affiliations
- Parc Científic de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- Karolinska University Hospital (SE)
- Inserm (FR)
- MRC Mitochondrial Biology Unit (GB)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 17190-17197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127806759
- Cited by
- 832
- References
- 50
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 28 · 2023: 49 · 2022: 32 · 2021: 40 · 2020: 63 · 2019: 45 · 2018: 52 · 2017: 45 · 2016: 48 · 2015: 32 · 2014: 47 · 2013: 49 · 2012: 54
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitofusin 2, mitochondrial fusion, mitochondrial metabolism, myogenesis, muscle mitochondria, mitochondrial fragmentation, glucose oxidation, mitochondrial membrane potential, cellular respiration, mitochondrial proton leak, obesity, mitochondrial membrane proteins
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Membrane Potentials, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Rats, Zucker, Muscle, Skeletal, GTP Phosphohydrolases, Mitochondrial Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.